Communications Director, Connecticut Hospital Association
110 Barnes Road, Wallingford, CT
rall@chime.org, 203-265-7611
Hartford Courant – Tuesday, September 9, 2025
By Wisteria Deng
In August, Yale New Haven Health confirmed it will no longer provide medication treatment as part of gender-affirming care for patients 19 and under. The announcement landed less than 24 hours after Connecticut Children’s Medical Center said it is “winding down” its entire gender-affirming care program for minors. What looks, on paper, like an administrative shift is, in practice, a rupture in care that will reverberate through the lives of trans youth, their parents, and the clinicians who have devoted their careers to evidence-based, family-centered medicine.
This is devastating to patients, their families and providers.
Neither hospital is acting because the science changed. Major medical bodies, from the American Academy of Pediatrics to the Pediatric Endocrine Society, continue to endorse gender-affirming care for appropriately screened adolescents. Connecticut Children’s said explicitly that its decision was driven by the “government landscape and pressure surrounding this care,” not new data about safety or efficacy. The chill is political: a Trump administration executive order targeting federal funding for institutions that provide youth gender-affirming care, a Department of Justice subpoena blitz, and a Supreme Court ruling in U.S. v. Skrmetti that green-lit statewide bans have made hospital lawyers, boards, and insurers flinch, even in comparatively protective states like Connecticut.
Yale will keep offering mental health support, but it is not a substitute for the medications (puberty blockers and hormones) that many teens already stabilized on will now lose access to locally. As a parent pointed out, “of course the need for mental health care will increase.”
For trans adolescents, continuity matters. Puberty doesn’t pause while hospital committees confer. Interruptions to blockers or hormones can mean irreversible physical changes, a return of dysphoria, and, for many, a spike in suicidality and self-harm risk.
Providers are trapped too. They’re being told to practice to the level of politics, not the level of their training or the consensus guidelines they swore to uphold. Among many other providers, I struggle to position myself in an institution that abandons patients I deeply care for and simultaneously be a grounding presence for them.
Elected officials from Gov. Ned Lamont to Attorney General William Tong have condemned federal interference and voiced support for affected families. However, I fail to see where either has done anything tangible to protect the trans youth of CT. There is more to be done:
- Pass (or strengthen) a medical “shield law” for providers who continue to treat minors from Connecticut and from ban states, protecting them from out-of-state subpoenas, licensing attacks, and criminal liability. (Several blue states have already done this; Connecticut can tailor one to minors specifically.)
- Create a state-funded bridge clinic and telehealth network so youth currently on medication are not forced into dangerous lapses in care. The state already sets up special clinics for other urgent public-health needs; do it here.
- Direct Access Health CT plans and Medicaid to continue covering youth gender-affirming care and to contract with out-of-state providers when in-state systems retreat. If federal policy tries to claw this back, litigate fast.
- Fund legal defense and malpractice backstops for clinicians who keep practicing to guideline standards. Hospitals are risk-averse; the state can lower the perceived risk.
- Start rapid-response navigator corps: social workers, attorneys, and peer advocates – to help families move prescriptions, secure records, and manage insurance transitions without weeks-long delays that can cause clinical harm.
Nationally, at least nine prominent hospitals or systems have curtailed or stopped youth gender-affirming care since June, even where state law doesn’t require it. This is what policy intimidation is designed to do: make courts and Congress almost beside the point by scaring institutions into self-censorship. If Yale New Haven Health – a system with prestige, resources, and a mandate to train the next generation of physicians – won’t hold the line on evidence-based care, who will?
As providers and clinicians, we swore “First, do no harm.” Harm is exactly what these cuts will do. Harm to the teen who suddenly can’t refill a blocker. Harm to the parent who now has to become a de facto case manager and interstate care courier. Harm to the provider who knows what best practice is but is forbidden from following it.
Allow patients to receive appropriate care. Allow parents to care for their kids. Allow providers to provide. It is simple as that.
Wisteria Deng, M.S., M.Phil., is a Clinical Fellow
